14Jan/14

Cell Therapeutics reaquire rights to two anti-cancer compounds from Novartis – pharmabiz.com


Drug Discovery & Development

Cell Therapeutics reaquire rights to two anti-cancer compounds from Novartis
pharmabiz.com
CTI is currently accruing patients into a phase III trial comparing Pixuvri and rituximab with gemcitabine and rituximab in the setting of aggressive B-cell NHL. Pixuvri does not have marketing approval in the United States. Opaxio (paclitaxel
Cell Therapeutics Reveals Drug Portfolio Progress, Outlook For 2014 – UpdateNASDAQ
Cell Therapeutics Inc : Cell Therapeutics Announces 2014 Outlook and Recent 4-traders (press release)

all 31 news articles »

14Jan/14

Congestive Heart Failure Leads to Debilitating Fatigue; polyDNA Recommends … – PR Web (press release)


PR Web (press release)

Congestive Heart Failure Leads to Debilitating Fatigue; polyDNA Recommends
PR Web (press release)
An article written by Dr. Tina M. St. John MD, and published on August 16, 2013 on Livestrong.com said that “Among people with advanced heart failure, fatigue typically proves severe (1).” polyDNA reviews the literature and recommends Gene-Eden-VIR to 

and more »

14Jan/14

Quirky rankings: Romania has best download speed, India, best movies … – Romania-Insider.com

Quirky rankings: Romania has best download speed, India, best movies
Romania-Insider.com
Meanwhile, the British are the best at “fascist movements”, the French at tourism, Spain at organ donation and Portugal at graduating high school. European economic powerhouse Germany takes the top spot at “almost winning the world cup”.

14Jan/14

Cell Therapeutics Reveals Drug Portfolio Progress, Outlook For 2014 – Update – NASDAQ


Drug Discovery & Development

Cell Therapeutics Reveals Drug Portfolio Progress, Outlook For 2014 – Update
NASDAQ
change the primary endpoint of the Phase 3 PIX-R, or PIX306, post-marketing commitment study of pixantrone-rituximab versus gemcitabine-rituximab for patients with relapsed B-cell non-Hodgkin lymphoma from overall survival to progression-free survival.
Cell Therapeutics reaquire rights to two anti-cancer compounds from Novartispharmabiz.com
Cell Therapeutics Inc.: Cell Therapeutics Announces 2014 Outlook and Recent The Wall Street Transcript

all 31 news articles »

14Jan/14

Proteins which play key role in limiting size of heart attacks identified – Daily News & Analysis


India.Com Health

Proteins which play key role in limiting size of heart attacks identified
Daily News & Analysis
Researchers have found that six proteins, five more than previously thought, are responsible for cell-to-cell communication that regulates the heart and plays a role in limiting the size of heart attacks and strokes. The researchers determined that the
Proteins needed to produce stable heartbeat identifiedBusiness Standard

all 10 news articles »